Drugs / J. Lividum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04315051 Comparator | Sep 2019 → Jun 2020 | tinea pedis | DermBiont, Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT04192513 Comparator | May 2019 → Jun 2020 | atopic eczema | DermBiont, Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | J. Lividum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04315051 ↗ |